A functional p.82G>S polymorphism in the RAGE gene is associated with multiple sclerosis in the Chinese population

Multiple Sclerosis Journal

Volumn 17, Issue 8, 2011, Pages 914-921

  Li, Keshen ^a   Zhao, Bin ^a   Dai, Dawei ^b   Yao, Songpo ^c   Liang, Wandong ^d   Yao, Lifen ^b   Yang, Ze ^e  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c JIAMUSI UNIVERSITY   (China)

^d WENZHOU MEDICAL UNIVERSITY   (China)

^e BEIJING HOSPITAL   (China)

Author keywords

association study; genetics; multiple sclerosis; polymorphism; receptor for advanced glycation end products

Indexed keywords

HLA DR ANTIGEN;

ADULT; ALLELE; ARTICLE; CHINESE; CONTROLLED STUDY; DISABILITY; DISEASE COURSE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENE LOCUS; GENOTYPE; HUMAN; LIGAND BINDING; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; POPULATION RESEARCH; RAGE GENE; RECURRENT DISEASE; REMISSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT;

EID: 80051965810     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511403529     Document Type: Article

References (29)

1. Barnett M, Prineas JW. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol. 2004 ; 55: 458-468 (Pubitemid 38391962)
2. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain. 1999 ; 122: 2279-2295
3. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998 ; 338: 278-285 (Pubitemid 28065253)
4. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci. 2001 ; 22: 117-139 (Pubitemid 33771279)
5. Cheng Q, Cheng XJ, Jiang GX. Multiple sclerosis in China-history and future. Mult Scler. 2009 ; 15: 655-660
6. Grigoriadis N, Grigoriadis S, Polyzoidou E, Milonas I, Karussis D. Neuroinflammation in multiple sclerosis: evidence for autoimmune dysregulation, not simple autoimmune reaction. Clin Neurol Neurosurg. 2006 ; 108: 241-244
7. Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest. 2001 ; 108: 949-955 (Pubitemid 32946067)
8. Park IH, Yeon SI, Youn JH, Choi JE, Sasaki N, Choi IH, et al. Expression of a novel secreted splice variant of the receptor for advanced glycation end products (RAGE) in human brain astrocytes and peripheral blood mononuclear cells. Mol Immunol. 2004 ; 40: 1203-1211 (Pubitemid 38210272)
9. Yan SS, Wu ZY, Zhang HP, Furtado G, Chen X, Yan SF, et al. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system. Nat Med. 2003 ; 9: 287-293 (Pubitemid 36362783)
10. Sternberg Z, Weinstock-Guttman B, Hojnacki D, Zamboni P, Zivadinov R, Chadha K, et al. Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity. Mult Scler. 2008 ; 14: 759-763
11. Hudson BI, Stickland MH, Grant PJ. Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups. Diabetes. 1998 ; 47: 1155-1157 (Pubitemid 28294561)
12. Hofmann MA, Drury S, Hudson BI, Gleason MR, Qu W, Lu Y, et al. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun. 2002 ; 3: 123-135 (Pubitemid 38961122)
13. Tiszlavicz Z, Gyulai Z, Bencsik K, Szolnoki Z, Kocsis AK, Somogyvári F, et al. RAGE gene polymorphisms in patients with multiple sclerosis. J Mol Neurosci. 2009 ; 39: 360-365
14. Caillier SJ, Briggs F, Cree BA, Baranzini SE, Fernandez-Viña M, Ramsay PP, et al. Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis. J Immunol. 2008 ; 181: 5473-5480
15. Jang Y, Kim JY, Kang SM, Kim JS, Chae JS, Kim OY, et al. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans. Metabolism. 2007 ; 56: 199-205 (Pubitemid 46074066)
16. Gaens KH, Ferreira I, van der Kallen CJ, van Greevenbroek MM, Blaak EE, Feskens EJ, et al. Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels. J Clin Endocrinol Metab. 2009 ; 94: 5174-5180
17. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001 ; 50: 121-127
18. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey: National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996 ; 46: 907-911
19. Tremmel M, Opelz G, Mytilineos J. High-resolution typing for HLA-DRB1*15 and -DRB1*16 by fluorescence-marked sequence-specific priming (TaqMan assay). Tissue Antigens. 1999 ; 54: 508-516
20. Gu H, Yang L, Sun Q, Zhou B, Tang N, Cong R, et al. Gly82Ser polymorphism of the receptor for advanced glycation end products is associated with an increased risk of gastric cancer in a Chinese population. Clin Cancer Res. 2008 ; 14: 3627-3632
21. Olerup O, Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens. 1991 ; 38: 1-15
22. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YC, et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem. 1992 ; 267: 14998-15004
23. Tanaka N, Yonekura H, Yamagishi S, Fujimori H, Yamamoto Y, Yamamoto H. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells. J Biol Chem. 2000 ; 275: 25781-25790
24. Geroldi D, Falcone C, Emanuele E. Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target. Curr Med Chem. 2006 ; 13: 1971-1978
25. Frohman EM, Filippi M, Stuve O, Waxman SG, Corboy J, Phillips JT, et al. Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions. Arch Neurol. 2005 ; 62: 1345-1356 (Pubitemid 41352050)
26. Chavakis T, Bierhaus A, Al-Fakhri N, Schneider D, Witte S, Linn T, et al. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med. 2003 ; 198: 1507-1515 (Pubitemid 37467165)
27. Bitsch A, Schuchardt J, Bunkowski S, Kuhlmann T, Brück W. Acute axonal injury in multiple sclerosis: correlation with demyelination and inflammation. Brain. 2000 ; 123: 1174-1183 (Pubitemid 30312109)
28. Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, et al. Gene map of the extended human MHC. Nat Rev Genet. 2004 ; 5: 889-899 (Pubitemid 39564252)
29. Okamoto K, Makino S, Yoshikawa Y, Takaki A, Nagatsuka Y, Ota M, et al. Identification of I kappa BL as the second major histocompatibility complex-linked susceptibility locus for rheumatoid arthritis. Am J Hum Genet. 2003 ; 72: 303-312 (Pubitemid 36194240)